According to Nataf et al., antibodies against GAD65, which are implicated in both type 1 diabetes and central nervous system disorders, often arise from two synergistic risk factors: immune challenges and psycho-emotional stress. The gene discussed is GAD2; the disease is type 1 diabetes mellitus.